| __timestamp | Halozyme Therapeutics, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 52602000 | 1162636000 |
| Thursday, January 1, 2015 | 105812000 | 1396725000 |
| Friday, January 1, 2016 | 113485000 | 1526100000 |
| Sunday, January 1, 2017 | 285461000 | 1619600000 |
| Monday, January 1, 2018 | 141726000 | 1429100000 |
| Tuesday, January 1, 2019 | 150446000 | 1331200000 |
| Wednesday, January 1, 2020 | 224227000 | 1375200000 |
| Friday, January 1, 2021 | 361897000 | 1563000000 |
| Saturday, January 1, 2022 | 520812000 | 1789600000 |
| Sunday, January 1, 2023 | 636892000 | 2070000000 |
Unlocking the unknown
In the competitive landscape of biotechnology, United Therapeutics Corporation and Halozyme Therapeutics, Inc. have shown distinct trajectories in their gross profit trends over the past decade. From 2014 to 2023, United Therapeutics has consistently outperformed, with a gross profit peaking at approximately $2.07 billion in 2023, marking a 78% increase from 2014. Meanwhile, Halozyme Therapeutics has demonstrated impressive growth, with a staggering 1,110% increase in gross profit, reaching around $637 million in 2023. This remarkable growth reflects Halozyme's strategic advancements and market penetration. The data highlights the dynamic nature of the biotech industry, where innovation and strategic positioning can lead to significant financial gains. As these companies continue to evolve, their financial trajectories offer valuable insights into the broader trends shaping the biotech sector.
Gross Profit Trends Compared: Novartis AG vs Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Sanofi vs Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Zoetis Inc. vs United Therapeutics Corporation
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing United Therapeutics Corporation and Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? United Therapeutics Corporation or Veracyte, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs MiMedx Group, Inc.
Key Insights on Gross Profit: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc.
Bio-Techne Corporation and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Ascendis Pharma A/S vs Halozyme Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.